国际肿瘤学杂志 ›› 2012, Vol. 39 ›› Issue (12): 898-902.

• 综述 • 上一篇    下一篇

髓样抑制性细胞的免疫抑制机制及其靶向治疗策略

温兰兰, 高全立, 买玲   

  1. 450008郑州大学附属肿瘤医院 河南省肿瘤医院 肿瘤生物治疗科
  • 出版日期:2012-12-08 发布日期:2012-11-15
  • 通讯作者: 买玲, E-mail: mailing5588134@yahoo.com.cn E-mail:mailing5588134@yahoo.com.cn

Mechanisms of immune suppression mediated by myeloid derived suppressor cell and the targeted therapy strategy

WEN  Lan-Lan, GAO  Quan-Li, MAI  Ling   

  1. Tumor Biological Therapy DivisionHenan Tumor Hospital Tumor Biological Therapy DivisionHenan Tumor Hospital Zhengzhou 450008, China
  • Online:2012-12-08 Published:2012-11-15
  • Contact: Corresponding author: MAI Ling, E-mail: mailing5588134@yahoo.com.cn E-mail:mailing5588134@yahoo.com.cn

摘要: 髓样抑制性细胞(MDSC)是一组来源于未成熟髓系细胞不同分化阶段的异质性细胞群体,可通过抑制T细胞及自然杀伤(NK)细胞的活性、诱导T-regs细胞的产生、参与肿瘤血管生成等多种途径诱导免疫抑制、介导免疫耐受,在肿瘤的发展和转移方面发挥着重要的作用。运用各种方法促进MDSC分化成熟,减少其数量、抑制其功能等可能有助于肿瘤患者正常免疫状态的恢复,控制肿瘤的进展,提高其他抗肿瘤治疗的疗效。靶向MDSC已成为肿瘤免疫治疗的新思路。

关键词: 髓系细胞, 免疫耐受, 免疫疗法

Abstract: Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells at different stages of maturation. MDSCs mediate the suppression of the anti-tumor immunity,and play a crucial role in cancer tolerance through suppressing the activity of T cells and natural killer cells ,inducing T-regs and involving the angiogenesis, and then contribute to the tumor development and metastasis. Promoting the differentiation of MDSCs, reducing its quantity and inhibiting its function by using various methods may contribute to the recovery of  patients normal immune status, the tumor progression control, and improvement of the efficacy of other anti-neoplastic therapies. Therefore,possible novel therapeutic approaches targeted at MDSCs could be considered and developed rapidly now.

Key words: Myeloid cells, Immune tolerance, Immunotherapy